TrialCancer2012

Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas.

Margaret von Mehren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.